Definitive Healthcare (NASDAQ:DH) Trading 7.1% Higher - What's Next?

Key Points

• Definitive Healthcare's stock increased by 7.1% and traded at $3.86, though trading volume was significantly lower than average.
• Analysts have mixed ratings on the stock, with one upgrade to "buy" and an average target price of $4.73, reflecting a cautious outlook among investment analysts.
• Institutional investors own 98.67% of Definitive Healthcare stock, indicating strong backing from large investment firms.

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report)'s stock price traded up 7.1% during trading on Wednesday . The company traded as high as $3.81 and last traded at $3.86. 91,220 shares were traded during trading, a decline of 89% from the average session volume of 838,096 shares. The stock had previously closed at $3.60.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on DH shares. Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. Stifel Nicolaus boosted their price target on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a report on Friday, August 8th. The Goldman Sachs Group boosted their price target on shares of Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a report on Monday, May 12th. Robert W. Baird set a $4.00 target price on Definitive Healthcare in a research note on Friday. Finally, BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $4.73.

Definitive Healthcare Stock Up 7.9%

The company has a current ratio of 1.65, a quick ratio of 1.75 and a debt-to-equity ratio of 0.39. The firm has a market cap of $577.47 million, a price-to-earnings ratio of -1.47, a PEG ratio of 5.92 and a beta of 1.64. The firm has a 50-day moving average of $3.90 and a two-hundred day moving average of $3.60.

Institutional Investors Weigh In On Definitive Healthcare

Several large investors have recently modified their holdings of DH. New York State Common Retirement Fund grew its position in Definitive Healthcare by 0.4% during the 2nd quarter. New York State Common Retirement Fund now owns 766,433 shares of the company's stock worth $2,989,000 after acquiring an additional 3,066 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Definitive Healthcare by 20.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after acquiring an additional 3,496 shares during the last quarter. Canada Pension Plan Investment Board grew its position in Definitive Healthcare by 18.1% during the 4th quarter. Canada Pension Plan Investment Board now owns 29,300 shares of the company's stock worth $120,000 after acquiring an additional 4,500 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Definitive Healthcare by 6.2% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company's stock worth $334,000 after acquiring an additional 4,748 shares during the last quarter. Finally, ProShare Advisors LLC grew its position in Definitive Healthcare by 49.1% during the 4th quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock worth $62,000 after acquiring an additional 4,943 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.